From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Wood Group won’t re-join the FTSE 100, but that’s not the forward story...

By Chris Bailey | Wednesday 1 June 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I am sure there will be some investors who are excited to hear that Centrica (CNA) shares are back to rejoin the FTSE 100, whilst others are disappointed that ITV (ITV) and Royal Mail (RMG) shares - among others - are exiting. None of the three interest me at the moment, but I was a bit disappointed that Johnson Matthey (JMAT) shares have not been quite strong enough to rejoin. Maybe that is coming next quarter as I believe the stock is cheap (as noted last week HERE). Another stock which did not return to the FTSE 100 (and frankly I don’t think it ever will) was Wood Group (WG.) but it has made a noteworthy announcement today…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:41:30